loadpatents
name:-0.026934146881104
name:-0.017013072967529
name:-0.0038111209869385
Kuang; Rongze Patent Filings

Kuang; Rongze

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kuang; Rongze.The latest application filed is for "factor xi activation inhibitors".

Company Profile
3.21.32
  • Kuang; Rongze - Green Brook NJ
  • KUANG; Rongze - Kenilwork NJ US
  • KUANG; Rongze - Greenbrook NJ
  • Kuang; Rongze - Rahway NJ US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Factor Xi Activation Inhibitors
App 20220235033 - Hicks; Jacqueline D. ;   et al.
2022-07-28
Substituted Amino Triazolopyrimidine And Amino Triazolopyrazine Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use
App 20220040184 - Brill; Zachary G. ;   et al.
2022-02-10
Substituted Amino Triazolopyrimidine And Amino Triazolopyrazine Adenosine Receptor Antagonists, Pharmaceutical Compositions And Their Use
App 20210395255 - Brill; Zachary G. ;   et al.
2021-12-23
2,2-difluorodioxolo A.sub.2A receptor antagonists
Grant 11,046,714 - Amjad , et al. June 29, 2
2021-06-29
Imidazo[1,2-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20210053973 - ALI; Amjad ;   et al.
2021-02-25
Substituted aminoquinazoline compounds as A.sub.2A antagonist
Grant 10,822,338 - Ali , et al. November 3, 2
2020-11-03
Aminopyrazine compounds with A2A antagonist properties
Grant 10,472,347 - Kuang , et al. Nov
2019-11-12
Substituted Aminoquinazoline Compounds As A2a Antagonist
App 20180362530 - Ali; Amjad ;   et al.
2018-12-20
Factor XIa inhibitors
Grant 10,143,681 - Shen , et al. De
2018-12-04
Aminoquinazoline compounds as A.sub.2A antagonist
Grant 10,138,212 - Ali , et al. Nov
2018-11-27
Aminopyrazine Compounds With A2a Antagonist Properties
App 20180327385 - KUANG; Rongze ;   et al.
2018-11-15
Factor XIa inhibitors
Grant 10,081,617 - Mertz , et al. September 25, 2
2018-09-25
Factor XIa inhibitors
Grant 10,011,585 - Liu , et al. July 3, 2
2018-07-03
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
Grant 10,011,615 - Ali , et al. July 3, 2
2018-07-03
FACTOR XIa INHIBITORS
App 20180079743 - Mertz; Eric ;   et al.
2018-03-22
FACTOR XIa INHIBITORS
App 20180050022 - Shen; Dong-Ming ;   et al.
2018-02-22
Aminoquinazoline Compounds As A2a Antagonist
App 20180037554 - Ali; Amjad ;   et al.
2018-02-08
Factor XIa inhibitors
Grant 9,868,727 - Liu , et al. January 16, 2
2018-01-16
Factor Xla inhibitors
Grant 9,783,530 - Liu , et al. October 10, 2
2017-10-10
FACTOR XIa INHIBITORS
App 20170240523 - Liu; Weiguo ;   et al.
2017-08-24
Factor XIa Inhibitors
App 20170210732 - Liu; Weiguo ;   et al.
2017-07-27
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20170197991 - Ali; Amjad ;   et al.
2017-07-13
FACTOR XIa INHIBITORS
App 20170197953 - Liu; Weiguo ;   et al.
2017-07-13
Piperazine-substituted [1,2,4]triazolo[1,5-C]quinazolin-5-amine compounds with A.sub.2A antagonist properties
Grant 9,676,780 - Ali , et al. June 13, 2
2017-06-13
2,2-difluorodioxolo A2a Receptor Antagonists
App 20160214997 - Amjad; Ali ;   et al.
2016-07-28
Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20160194330 - Ali; Amjad ;   et al.
2016-07-07
Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine Compounds With A2a Antagonist Properties
App 20150361098 - Ali; Amjad ;   et al.
2015-12-17
Inhibitors of diacylglycerol acyltransferase
Grant 8,716,312 - Ting , et al. May 6, 2
2014-05-06
Imidazole Derivatives
App 20140088124 - DeVita; Robert J. ;   et al.
2014-03-27
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
Grant 8,569,312 - McCormick , et al. October 29, 2
2013-10-29
Biaryl-spiroaminooxzaoline Analogues As Alpha 2c Adrenergic Receptor Modulators
App 20130225582 - McCormick; Kevin D. ;   et al.
2013-08-29
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
Grant 8,476,274 - McCormick , et al. July 2, 2
2013-07-02
Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators
App 20130045914 - McCormick; Kevin D. ;   et al.
2013-02-21
Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators
Grant 8,324,213 - McCormick , et al. December 4, 2
2012-12-04
Pyridazinone derivatives useful as glucan synthase inhibitors
Grant 8,232,274 - Ting , et al. July 31, 2
2012-07-31
Biaryl-spiroaminooxazoline Analogues As Alpha 2c Adrenergic Receptor Modulators
App 20110251207 - McCormick; Kevin D. ;   et al.
2011-10-13
Inhibitors Of Diacylglycerol Acyltransferase
App 20110224136 - Ting; Pauline C. ;   et al.
2011-09-15
Inhibitors Of Diacylglycerol Acyltransferase
App 20110224193 - Ting; Pauline C. ;   et al.
2011-09-15
Inhibitors Of Diacylglycerol Acyltransferase
App 20110224137 - Ting; Pauline C. ;   et al.
2011-09-15
Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methox- y-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore
Grant 7,956,189 - Chen , et al. June 7, 2
2011-06-07
Pyridazinone Derivatives Useful as Glucan Synthase Inhibitors
App 20090170861 - Ting; Pauline C. ;   et al.
2009-07-02
Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
Grant 7,511,062 - Kuang , et al. March 31, 2
2009-03-31
Maleate, tosylate, fumarate and oxalate salts of 5-(1-(S)-amino-2-hydroxyethyl)-N-[(2,4-difluorophenyl)-methy]-2-[8-methox- y-2-(triflouromethy)-5-quinoline]-4-oxazolecarboxamide and preparation process therefore
App 20080108818 - Chen; Xiaoming ;   et al.
2008-05-08
Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors
App 20060106062 - Kuang; Rongze ;   et al.
2006-05-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed